EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins

Ferhat Ekinci, Utku Erdem Soyaltın, Harun Akar, Mehmet Can Ugur, Ercan Ersoy, Andac Komac, Tuba Demirci Yildirım

BANTAO Journal · 2015

DOI: 10.1515/bj-2015-0019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BANTAO Journal, 2015. Verfasst von Ferhat Ekinci und 6 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic systemic capillary leak syndrome (ISCLS) is characterized by a triad of hypotension, hemoconcentration and hypoalbuminemia due to a shift of intravascular fluid and albumin to the extravascular area. We describe a hypovolemic patient with hemoconcentration and hypoalbuminemia who was successfully treated with high-dose intravenous immunoglobulins (IVIG). The purpose of this case report is to discuss the clinical management of idiopathic systemic capillary leak syndrome on the background of relevant literature review.

Zitieren

APA

Ekinci, F., Soyaltın, U. E., Akar, H., Ugur, M. C., Ersoy, E., Komac, A., & Yildirım, T. D. (2015). Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins. BANTAO Journal. https://doi.org/10.1515/bj-2015-0019

Vancouver

Ekinci F, Soyaltın UE, Akar H, Ugur MC, Ersoy E, Komac A, et al. Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins. BANTAO Journal. 2015. doi:10.1515/bj-2015-0019

BibTeX
@article{Ekinci2015,
  author = {Ekinci, Ferhat and Soyaltın, Utku Erdem and Akar, Harun and Ugur, Mehmet Can and Ersoy, Ercan and Komac, Andac and Yildirım, Tuba Demirci},
  title = {Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins},
  journal = {BANTAO Journal},
  year = {2015},
  doi = {10.1515/bj-2015-0019}
}
Kostenlos starten →